A number of market participants also consider, to varying degrees, that the market
is generally switching towards GM produced lactase. One manufacturer notes there is a: “clear move to GM produced lactase. This is a global trend where non-GM lactases are being replaced by GM ones, where possible”63 which leads it to “firmly believe that GM produced lactase will become more dominant in the market”.64 On the other hand, one manufacturer notes that: “some customers would prefer to only buy one type of lactase rather than multiple different types and would therefore purchase just a non-GM lactase as it can be used for both organic/non-GM labelled products as well as non-organic applications”.65 54 eRFI to competitors and distributors, question B.9. 55 eRFI to competitors and distributors, question B.11. 56 eRFI to competitors and distributors, question B.9. 57 Form CO. para. 960. 58 Minutes of a call with a manufacturer on 10 October 2023, para. 9. 59 eRFI to competitors and distributors, question B.9. 60 Form CO. para. 1014. 61 Form CO. para. 1018. 62 Form CO. para. 1023. 63 Minutes of a call with a manufacturer on 10 October 2023, para. 16. 64 Minutes of a call with a manufacturer on 10 October 2023, para. 16. 65 Minutes of a call with a manufacturer on 25 September 2023, para. 8.